Astrazeneca coronavirus vaccine trial on hold after 'unexplained illness' Sep. 9, 2020 By Michael Fitzhugh No Comments A phase III trial of AZD-1222, an experimental coronavirus vaccine developed by Astrazeneca plc and Oxford University, has been paused due to an unexplained illness that occurred in the U.K., the company said on Sept. 8. Read More